KR20210046412A - Compositions containing defatted microalgae extract - Google Patents
Compositions containing defatted microalgae extract Download PDFInfo
- Publication number
- KR20210046412A KR20210046412A KR1020190130081A KR20190130081A KR20210046412A KR 20210046412 A KR20210046412 A KR 20210046412A KR 1020190130081 A KR1020190130081 A KR 1020190130081A KR 20190130081 A KR20190130081 A KR 20190130081A KR 20210046412 A KR20210046412 A KR 20210046412A
- Authority
- KR
- South Korea
- Prior art keywords
- microalgae
- enzyme
- skim
- cosmetic composition
- protein
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 239000000284 extract Substances 0.000 title description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 75
- 108090000790 Enzymes Proteins 0.000 claims abstract description 75
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 37
- 239000002537 cosmetic Substances 0.000 claims abstract description 34
- 239000004480 active ingredient Substances 0.000 claims abstract description 14
- 230000002087 whitening effect Effects 0.000 claims abstract description 10
- 230000036560 skin regeneration Effects 0.000 claims abstract description 7
- 102000035195 Peptidases Human genes 0.000 claims description 35
- 108091005804 Peptidases Proteins 0.000 claims description 35
- 230000000694 effects Effects 0.000 claims description 32
- 241000315694 Bacillus tequilensis Species 0.000 claims description 24
- 235000013376 functional food Nutrition 0.000 claims description 15
- 230000036541 health Effects 0.000 claims description 15
- 238000005238 degreasing Methods 0.000 claims description 13
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 9
- 239000005515 coenzyme Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 230000003301 hydrolyzing effect Effects 0.000 claims description 6
- 240000002900 Arthrospira platensis Species 0.000 claims description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 2
- 229940082787 spirulina Drugs 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 72
- 230000000052 comparative effect Effects 0.000 description 41
- 235000018102 proteins Nutrition 0.000 description 38
- 102000004169 proteins and genes Human genes 0.000 description 38
- 108090000623 proteins and genes Proteins 0.000 description 38
- 239000000047 product Substances 0.000 description 36
- 108090000765 processed proteins & peptides Proteins 0.000 description 31
- 239000000243 solution Substances 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 19
- 102000003425 Tyrosinase Human genes 0.000 description 17
- 108060008724 Tyrosinase Proteins 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 14
- 102000029816 Collagenase Human genes 0.000 description 13
- 108060005980 Collagenase Proteins 0.000 description 13
- 229960002424 collagenase Drugs 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 239000006210 lotion Substances 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 239000004365 Protease Substances 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000002144 chemical decomposition reaction Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 230000006862 enzymatic digestion Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000002797 proteolythic effect Effects 0.000 description 7
- -1 restrictors Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000008099 melanin synthesis Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 241001474374 Blennius Species 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 235000019784 crude fat Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007071 enzymatic hydrolysis Effects 0.000 description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000013587 production medium Substances 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- 235000019750 Crude protein Nutrition 0.000 description 3
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 3
- 229960004705 kojic acid Drugs 0.000 description 3
- 108010009355 microbial metalloproteinases Proteins 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 201000000849 skin cancer Diseases 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229940079894 benzophenone-9 Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000004182 chemical digestion Methods 0.000 description 2
- 230000007073 chemical hydrolysis Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000013777 protein digestion Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 2
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VIYKYVYAKVNDPS-HKGPVOKGSA-N (2s)-2-azanyl-3-[3,4-bis(oxidanyl)phenyl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 VIYKYVYAKVNDPS-HKGPVOKGSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- WLJYNHBZKOQNNI-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-[2-[[4-methyl-2-[[1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 108010001949 Algal Proteins Proteins 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 101000933967 Pseudomonas phage KPP25 Major capsid protein Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000196321 Tetraselmis Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000000184 acid digestion Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002796 poly[α-(4-aminobutyl)-L-glycolic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037370 skin discoloration Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- C12R1/07—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 탈지미세조류 효소분해물을 유효성분으로 포함하는 화장료 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a cosmetic composition and a health functional food comprising an enzyme decomposition product of skim microalgae as an active ingredient.
최근 오존층 파괴로 인해 지표면에 도달하는 자외선 증가로 인한 피부손상이 지속적으로 증가하고 있다. 피부가 자외선 자극을 받으면 각질형성 세포에서 호르몬과 일산화질소 등이 분비되어 피부 색소가 증가하게 되어 피부착색과 노화를 촉진하게 된다. In recent years, due to the destruction of the ozone layer, skin damage due to an increase in ultraviolet rays reaching the surface has been continuously increasing. When the skin is stimulated with ultraviolet rays, hormones and nitrogen monoxide are secreted from keratinocytes, increasing skin pigmentation, promoting skin pigmentation and aging.
피부착색은 멜라닌 색소에 의해 발생하며, 자외선으로부터 피부를 보호하는 기능을 한다고 알려져 있지만 과도한 멜라닌 생성은 색소침착 외에 피부암과 같은 질환을 일으키는 것으로 알려져 있다. 멜라닌은 타이로신을 기질로 타이로시네이즈에 의해 3,4-dihydroxy-phenylalanine(DOPA)를 거쳐 DOPA 퀴논(quinone)으로 전환되고, 자동산화반응과 효소반응으로 DOPA 크롬(chrome)을 거쳐 생성된다. 멜라닌 생성과정에서 타이로시네이즈가 주요 효소로 알려져 있으며 최근에 멜라닌 색소의 생산 감소 또는 제거를 위해 타이로시네이즈 활성 저해에 대한 연구가 활발히 이루어지고 있다.Skin pigmentation is caused by melanin pigment and is known to protect the skin from ultraviolet rays, but excessive melanin production is known to cause diseases such as skin cancer in addition to pigmentation. Melanin is converted to DOPA quinone through 3,4-dihydroxy-phenylalanine (DOPA) by tyrosine as a substrate using tyrosine as a substrate, and is produced through DOPA chrome through automatic oxidation and enzymatic reactions. Tyrosinase is known as a major enzyme in the process of melanin production, and recently, studies on inhibition of tyrosinase activity have been actively conducted in order to reduce or eliminate the production of melanin pigments.
현재 가장 널리 이용되고 있는 피부 미백제는 화학적 합성물질인 알부틴(arbutin)과 코직산(kojic acid)인데 알부틴은 타이로신과 경쟁적으로 작용하는 저해제로 알려져 있으며 코직산은 타이로시네이즈 활성 부위를 불활성화시켜 DOPA 생산을 방해하여 멜라닌 색소 생성을 저해한다고 알려져 있다. 하지만, 코직산은 피부 변색 및 피부암 유발 가능성 등의 안정성 문제 등으로 사용이 제한되고 있으며 알부틴은 빛이나 효소 등에 의해 발암물질로 의심되는 하이드로퀴논(hydroquinone)의 생성된다고 알려져 장기적 사용에 위험성이 있다. Currently, the most widely used skin whitening agents are arbutin and kojic acid, which are chemically synthesized substances. Arbutin is known as an inhibitor that acts competitively with tyrosine, and kojic acid inactivates the active site of tyrosine to produce DOPA. It is known to inhibit the production of melanin pigment by interfering with. However, use of kojic acid is limited due to stability problems such as skin discoloration and skin cancer potential, and arbutin is known to produce hydroquinone, which is suspected as a carcinogen, by light or enzymes, and has a risk for long-term use.
이에 기존 화학합성 미백제가 갖는 단점을 극복하기 위해 천연에서 유래되는 미백 소재 개발에 대한 필요성이 높아지는 실정이다. 천연에서 유래되는 대부분의 미백 또는 항노화 소재들은 국화, 삼백초, 맨드라미 추출물 또는 한약재 등 육상식물이 높은 비중을 차지하고 있지만, 해양 생물은 생물종이 다양하고 해양 환경의 특이성으로 우수한 성능의 생리활성 물질이 생산된다고 보고되고 있어 고부가가치 소재 원료로 각광받고 있다. Accordingly, there is a growing need for the development of natural-derived whitening materials in order to overcome the shortcomings of existing chemically synthesized whitening agents. Most of the whitening or anti-aging materials derived from nature occupy a high proportion of land plants, such as chrysanthemum, serrata, cockscomb extract, or medicinal herbs, but marine organisms have a variety of species and produce physiologically active substances with excellent performance due to the peculiarity of the marine environment. It is reported that it is becoming a high value-added material.
해양식물 중 해조류는 다양한 단백질과 다당류를 포함하고 풍부한 무기질과 비타민이 함유되어 있어 생리활성물질 생산을 위한 소재로 많은 관심을 받고 있다. Manou 등에 따르면 해조류는 육상 식물보다 우수한 항산화, 약리활성, 항종양, 항염증 및 면역조절을 포함한 다양한 생리활성물질 등을 포함하고 있어 미백과 항산화 기능성 화장품 소재로도 활용이 가능하다.Among marine plants, seaweeds are attracting a lot of attention as a material for the production of physiologically active substances because they contain various proteins and polysaccharides and contain abundant minerals and vitamins. According to Manou et al., seaweeds contain various physiologically active substances including antioxidants, pharmacological activities, anti-tumor, anti-inflammatory and immunomodulatory, which are superior to land plants, so they can be used as whitening and antioxidant functional cosmetic materials.
이러한 해조류의 생리활성 기능은 다당류와 단백질의 저분자 형태인 펩타이드에서 기인한다고 보고되고 있다. 천연물에 존재하는 단백질 분해를 통해 생산되는 펩타이드는 크기가 작아 생체 조직에 쉽게 흡수될 수 있으며, 주름개선과 콜라겐 합성을 증대시키는 특성을 가지고 있어 차세대 소재로 화장품 및 의약 분야에서 다양한 연구가 지속되고 있다. 특히, 아미노산의 개수가 18개 이하로 구성된 펩타이드는 활성산소 억제, 피부세포 재생, 세포분열 촉진, 주름개선 등에 효과가 있다고 알려져 화장품, 기능성식품 및 의약품으로 사용이 확대되는 실정이다. It is reported that the physiologically active function of these algae is due to the low-molecular form of polysaccharides and proteins. Peptides produced through protein decomposition present in natural products are small in size and can be easily absorbed into living tissues, and have the properties of improving wrinkles and increasing collagen synthesis, so various researches are ongoing in the cosmetics and medicine fields as a next-generation material. . In particular, peptides composed of 18 or less amino acids are known to be effective in inhibiting free radicals, regenerating skin cells, promoting cell division, and improving wrinkles, and are widely used in cosmetics, functional foods, and pharmaceuticals.
그러나, 단백질 분해에 있어 산 또는 염기를 이용한 화학적 분해는 식품 및 화장품 사용에 안전성 문제와 소비자 거부감 증대로 인해 사용이 제한되고 있으며, 상업효소를 이용한 효소적 분해는 식품 및 화장품 첨가제로의 허가문제와 고가의 효소가격으로 인해 제품 비용 증가하는 단점을 지닌다. 이러한 화학적 분해에 의한 펩타이드 생산 및 상업효소를 이용한 펩타이드 생산의 단점을 극복하기 위해 보다 안전하고 저비용의 효소를 이용한 펩타이드 생산의 필요성이 높아지고 있다.However, in protein decomposition, chemical decomposition using acids or bases is restricted due to safety issues and increased consumer rejection in the use of food and cosmetics, and enzymatic decomposition using commercial enzymes is a problem with permission for food and cosmetic additives. It has the disadvantage of increasing product cost due to the expensive enzyme price. In order to overcome the shortcomings of the production of peptides by chemical decomposition and the production of peptides using commercial enzymes, the need for production of peptides using more safe and low-cost enzymes is increasing.
한편, 신재생 에너지의 필요성이 높아지면서 해조류의 한 종류인 미세조류는 지질 추출을 통해 바이오디젤을 생산하는 제3세대 바이오매스로 그 활용도가 높아지고 있다. 하지만, 지질 생산 후 버려지는 탈지미세조류에는 단백질 함량이 높음에도 불구하고 저급의 사료로 사용되거나 폐기되는 현실로 재활용에 대한 연구가 미흡한 실정이다. Meanwhile, as the need for new and renewable energy increases, microalgae, a type of seaweed, is a third generation biomass that produces biodiesel through lipid extraction, and its utilization is increasing. However, despite the high protein content in skim microalgae discarded after lipid production, it is used or discarded as a low-grade feed, so research on recycling is insufficient.
따라서, 종래의 화학적 분해 또는 상업효소를 이용한 효소적 분해 대신 새로운 천연 유래 효소를 이용하여 탈지미세조류를 가수분해시킨 효소분해물을 포함하는 조성물이 요구되고 있다.Therefore, there is a need for a composition comprising an enzymatic digestion product obtained by hydrolyzing defatted microalgae using a new naturally-derived enzyme instead of a conventional chemical digestion or enzymatic digestion using a commercial enzyme.
본 발명의 목적은 탈지미세조류 효소분해물을 유효성분으로 포함하는 화장료 조성물을 제공하는데 있다.It is an object of the present invention to provide a cosmetic composition comprising an enzyme decomposition product of skim microalgae as an active ingredient.
또한, 본 발명의 다른 목적은 탈지미세조류 효소분해물을 유효성분으로 포함하는 건강기능식품을 제공하는데 있다.In addition, another object of the present invention is to provide a health functional food comprising an enzyme decomposition product of skim microalgae as an active ingredient.
또한, 본 발명의 또 다른 목적은 전통장류로부터 분리된 신규 균주를 제공하는데 있다.In addition, another object of the present invention is to provide a new strain isolated from traditional paste.
상기한 목적을 달성하기 위한 본 발명의 화장료 조성물은 탈지미세조류(lipid-extracted microalgae)를 단백질 분해효소로 가수분해한 탈지미세조류 효소분해물을 유효성분으로 포함할 수 있다.The cosmetic composition of the present invention for achieving the above object may include, as an active ingredient, an enzyme decomposition product of a skim microalgae obtained by hydrolyzing a lipid-extracted microalgae with a proteolytic enzyme.
상기 탈지미세조류는 테트라셀미스, 스피루리나, 클로렐라 또는 식물성 플라크톤을 탈지시킨 것일 수 있다.The defatted microalgae may be one obtained by defatting tetracelmis, spirulina, chlorella, or vegetable plakton.
상기 단백질 분해효소는 바실러스 테퀼엔시스(B. tequilensis) SM18[기탁번호: BP1429751]을 배양한 상등액(조효소액)일 수 있다. The protease may be a supernatant (coenzyme solution) obtained by culturing Bacillus tequillensis (B. tequilensis) SM18 [Accession No. BP1429751].
상기 탈지미세조류와 단백질 분해효소는 1 : 2-20의 고액비로 혼합될 수 있다.The skim microalgae and proteolytic enzyme may be mixed in a high-liquid ratio of 1:2-20.
상기 화장료 조성물은 피부 미백 및 피부 재생 효과를 갖는 것일 수 있다.The cosmetic composition may have skin whitening and skin regeneration effects.
또한, 상기한 다른 목적을 달성하기 위한 본 발명의 건강기능식품은 탈지미세조류(lipid-extracted microalgae)를 단백질 분해효소로 가수분해한 탈지미세조류 효소분해물을 유효성분으로 포함할 수 있다.In addition, the health functional food of the present invention for achieving the above-described other object may contain as an active ingredient an enzyme decomposition product of defatted microalgae obtained by hydrolyzing a lipid-extracted microalgae with a proteolytic enzyme.
또한, 상기한 또 다른 목적을 달성하기 위한 본 발명의 신규한 균주는 전통장류로부터 분리된 바실러스 테퀼엔시스(B. tequilensis SM18; 기탁번호 BP1429751)일 수 있다. In addition, the novel strain of the present invention for achieving the another object described above may be Bacillus tequillensis isolated from traditional paste (B. tequilensis SM18 ; accession number BP1429751).
본 발명의 탈지미세조류 효소분해물을 포함하는 조성물은 종래의 화학적 분해 또는 상업효소를 이용한 효소적 분해 대신 전통장류로부터 분리된 바실러스 테퀼엔시스(B. tequilensis SM18; 기탁번호 BP1429751) 효소를 이용하여 탈지미세조류를 분해함으로써 독성이 없으며, 피부 미백 및 피부 재생에 효과적이다.The composition comprising the enzyme decomposition product of skim microalgae of the present invention is finely degreased using the enzyme B. tequilensis SM18 ; Accession No. BP1429751) isolated from traditional soybeans instead of conventional chemical degradation or enzymatic degradation using commercial enzymes. It is not toxic by decomposing algae, and is effective for skin whitening and skin regeneration.
상기 전통장류로부터 분리된 신규한 바실러스 바실러스 테퀼엔시스(B. tequilensis SM18; 기탁번호 BP1429751) 효소는 안전하고 저렴할 뿐만 아니라 단백질 분해효소 활성이 우수하다.The novel Bacillus Bacillus tequillensis (B. tequilensis SM18 ; Accession No. BP1429751) enzyme isolated from the traditional paste is safe and inexpensive, as well as excellent protease activity.
도 1은 청국장에서 분리한 여러 종류의 균주를 접종하여 clear zone을 형성하는 균주를 확인한 사진이다.
도 2는 청국장에서 분리한 18종의 균주의 단백질분해 활성을 측정한 그래프이다.
도 3은 비교예 5 내지 8에 따라 화학적 가수분해에 따른 단백질 분자량의 변화를 확인하기 위하여 SDS-PAGE를 이용함으로써 단백질 분자량을 비교한 것이다.
도 4는 비교예 1 내지 4에 따라 시판용 효소를 이용한 효소적 가수분해에 따른 단백질 분자량의 변화를 확인하기 위하여 SDS-PAGE를 이용함으로써 단백질 분자량을 비교한 것이다.
도 5는 실시예 1 및 비교예 1에 따라 상이한 효소를 사용 시 효소적 가수분해에 따른 단백질 분자량의 변화를 확인하기 위하여 SDS-PAGE를 이용함으로써 단백질 분자량을 비교한 것이다.1 is a photograph confirming the strain forming a clear zone by inoculating various strains isolated in Cheonggukjang.
2 is a graph measuring the proteolytic activity of 18 strains isolated from Cheonggukjang.
3 is a comparison of protein molecular weights by using SDS-PAGE to confirm the change in protein molecular weight due to chemical hydrolysis according to Comparative Examples 5 to 8.
4 is a comparison of protein molecular weights by using SDS-PAGE in order to confirm the change in protein molecular weight due to enzymatic hydrolysis using commercially available enzymes according to Comparative Examples 1 to 4.
5 is a comparison of protein molecular weights by using SDS-PAGE to confirm the change in protein molecular weight due to enzymatic hydrolysis when using different enzymes according to Example 1 and Comparative Example 1. FIG.
본 발명은 탈지미세조류 효소분해물을 유효성분으로 포함하는 화장료 조성물 및 건강기능식품에 관한 것이다.
The present invention relates to a cosmetic composition and a health functional food comprising an enzyme decomposition product of skim microalgae as an active ingredient.
이하, 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명의 화장료 조성물은 탈지미세조류 효소분해물을 유효성분으로 포함한다.The cosmetic composition of the present invention contains an enzyme decomposition product of skim microalgae as an active ingredient.
미세조류(microalgae)는 바다에 서식하는 식물성 플랑크톤으로, 흔히 적조를 일으키는 코클로디니움 같은 플랑크톤 역시 미세조류에 속한다. 해양 바이오에너지 연구가 주목하는 미세조류는 특히 지질, 즉 기름성분이 풍부한 미세조류 종(種)이다. 크기는 10 μm(미크론, 1 m의 100만분의 1)정도로 머리카락 굵기의 10분의 1 안팎이다.Microalgae are phytoplankton living in the sea, and plankton such as coclodinium, which often causes red tides, are also included in microalgae. The microalgae that marine bioenergy research focuses on are particularly lipid-rich microalgae species. The size is about 10 μm (micron, 1 millionth of 1 m), about a tenth of the thickness of a hair.
본 발명의 탈지미세조류(LEM)는 미세조류 배양 후 지질을 추출하고 잔류한 고체 부산물을 말하며 일반적으로 미세조류 건조중량의 30-60%를 차지한다. 탈지미세조류는 잔류 지질 외에 다량의 단백질이 함유되어 있는데 다른 곡류에 비해 많은 양의 단백질(22-25%)을 함유하고 있으며 단백질 아미노산 조성이 다양하여 필수아미노산도 풍부하게 포함되어 있다.The defatted microalgae (LEM) of the present invention refers to a solid by-product remaining after extracting lipids after cultivation of microalgae, and generally accounts for 30-60% of the dry weight of microalgae. In addition to residual lipids, skim microalgae contains a large amount of protein. Compared to other cereals, skim microalgae contain a large amount of protein (22-25%), and the protein amino acid composition is varied, so essential amino acids are also abundant.
본 발명의 탈지미세조류를 가수분해시키는 단백질 분해효소는 전통장류에서 분리된 균주를 배양한 후 원심분리로 얻은 상등액으로서, 상기 전통장류로는 청국장, 된장 또는 간장을 들 수 있으며, 바람직하게는 청국장을 들 수 있다. 상기 전통장류는 안정성이 검증되어 있는 식품일 수 있다. The proteolytic enzyme for hydrolyzing skim microalgae of the present invention is a supernatant obtained by centrifugation after culturing a strain isolated from traditional paste, and the traditional paste may include cheonggukjang, soybean paste, or soy sauce, preferably cheonggukjang Can be mentioned. The traditional paste may be a food whose stability has been verified.
상기 전통장류로부터 분리한 균주를 각각 동정한 결과 바실러스 테퀼엔시스(B. tequilensis)에 속하며, 이를 바실러스 테퀼엔시스(B. tequilensis) SM18로 명명하고, 2019년 03월 04일자로 생물자원센터(KCTC: Korean Collection for Type Cultures)에 기탁하여 기탁번호를 BP1429751로 부여받았다. As a result of identifying each strain isolated from the traditional paste, it belongs to Bacillus tequillensis (B. tequilensis ), which was named as Bacillus tequillensis (B. tequilensis) SM18, and as of March 04, 2019, the Center for Biological Resources (KCTC: Korean Collection for Type Cultures), and the deposit number was assigned as BP1429751.
상기 탈지미세조류와 단백질 분해효소는 1 : 2-20의 고액비, 바람직하게는 1 : 5-20의 고액비로 혼합된다. 탈지미세조류의 함량을 기준으로 단백질 분해효소의 함량이 상기 하한치 미만인 경우에는 단백질의 가수분해가 수행되지 않을 수 있으며, 상기 상한치 초과인 경우에는 피부 트러블이 발생하여 화장료 조성물로 사용하지 못할 수 있다.The skim microalgae and the proteolytic enzyme are mixed in a high-liquid ratio of 1:2-20, preferably in a high-liquid ratio of 1:5-20. If the content of the proteolytic enzyme based on the content of skim microalgae is less than the lower limit, the hydrolysis of the protein may not be performed, and if it exceeds the upper limit, skin trouble may occur, and thus it may not be used as a cosmetic composition.
본 발명의 탈지미세조류 효소분해물은 화장료 조성물 외에 건강기능식품에도 사용될 수 있다.
The enzyme decomposition product of skim microalgae of the present invention can be used in health functional foods in addition to cosmetic compositions.
본 명세서에서 용어 '유효성분으로 함유하는'이란 탈지미세조류 효소분해물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 일예로, 상기 탈지미세조류 효소분해물은 20 내지 400 unit/㎖, 바람직하게는 100 내지 200 unit/㎖의 농도로 사용된다. 탈지미세조류 효소분해물은 천연물로서 과량 사용하여도 인체에 부작용이 없으므로 본 발명의 조성물 내에 포함되는 탈지미세조류 효소분해물의 양적 상한은 당업자가 적절한 범위 내에서 선택하여 실시할 수 있다.In the present specification, the term "contained as an active ingredient" means including an amount sufficient to achieve the efficacy or activity of the enzyme decomposition product of defatted microalgae. For example, the enzyme decomposition product of skim microalgae is used at a concentration of 20 to 400 unit/ml, preferably 100 to 200 unit/ml. Since the degreasing microalgal enzyme decomposition product is a natural product and does not have side effects on the human body even if it is used in an excessive amount, the upper limit of the quantity of the defatted microalgal enzyme decomposition product contained in the composition of the present invention can be selected and carried out by a person skilled in the art within an appropriate range.
본 발명의 화장료 조성물에는 상기의 화장료 조성물과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합할 수 있으며, 이러한 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한제, 정제수, 수용성 비타민, 지용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스 등을 들 수 있다.In the cosmetic composition of the present invention, in addition to the cosmetic composition described above, other ingredients that are usually blended in the cosmetic may be blended as needed, and such blending ingredients include fats and oils, moisturizers, emollients, surfactants, organic and inorganic pigments, Organic powders, UV absorbers, preservatives, disinfectants, antioxidants, pH adjusters, alcohols, pigments, fragrances, blood circulation accelerators, cooling agents, restrictors, purified water, water-soluble vitamins, fat-soluble vitamins, polymer peptides, polymer polysaccharides, sphingo lipids and seaweed Extract, etc. are mentioned.
본 발명의 화장료 조성물은 당업계에서 통상 사용되는 유화 제형 및 가용화 제형의 형태로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in the form of an emulsified formulation and a solubilized formulation commonly used in the art.
또한, 본 발명의 상기 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 성분 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 안료 및 천연향료와 같은 통상적인 보조제 및 담체를 더 포함할 수 있다.In addition, the ingredients included in the cosmetic composition of the present invention may include ingredients commonly used in cosmetic compositions in addition to the above ingredients as an active ingredient. For example, conventional auxiliary agents such as stabilizers, pigments and natural perfumes, and It may further include a carrier.
본 발명의 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 미스트, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 자외선 차단크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 마스크팩, 프레스파우더, 루스파우더, 아이섀도우 등과 같은 화장품류와 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저 등이 있다.Products to which the composition of the present invention can be added include, for example, mist, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrition lotion, massage cream, nutrition cream, sunscreen cream , Moisture Cream, Hand Cream, Foundation, Essence, Nutrition Essence, Mask Pack, Press Powder, Loose Powder, Cosmetics such as Eye Shadow, Soap, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion and Body Cleanser.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide may be used as a carrier component. I can.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additionally chlorofluorohydrocarbon, propane , Butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, a solvating agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.
When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracant, and the like may be used.
또한, 본 발명은 탈지미세조류 효소분해물을 유효성분으로 함유하는 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition containing an enzyme decomposition product of skim microalgae as an active ingredient.
건강기능식품이란, 탈지미세조류 효소분해물을 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡슐화, 분말화, 현탁액 등으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 것을 의미하나, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용시 발생할 수 있는 부작용 등이 없는 장점이 있다. 이와 같이 하여 얻어지는 본 발명의 건강기능식품은, 일상적으로 섭취하는 것이 가능하기 때문에 매우 유용하다. 이와 같은 건강기능식품에 있어서의 탈지미세조류 효소분해물의 첨가량은, 대상인 건강기능식품의 종류에 따라 달라 일률적으로 규정할 수 없지만, 식품 본래의 맛을 손상시키지 않는 범위에서 첨가하면 되며, 대상 식품에 대하여 통상 0.01 내지 50 중량%, 바람직하기로는 0.1 내지 20 중량%의 범위이다. 또한, 환제, 과립제, 정제 또는 캡슐제 형태의 건강기능식품의 경우에는 통상 0.1 내지 100 중량% 바람직하기로는 0.5 내지 80 중량%의 범위에서 첨가하면 된다. 한 구체예에서, 본 발명의 건강기능식품은 환제, 정제, 캡슐제 또는 음료의 형태일 수 있다.
Health functional foods are foods prepared by adding enzyme decomposition products of skim microalgae to food materials such as beverages, teas, spices, gums, confectionery, or encapsulated, powdered, or suspended. It means to bring it, but unlike general drugs, it has the advantage of not having side effects that may occur when taking the drug for a long time by using food as raw material. The health functional food of the present invention obtained in this way is very useful because it can be consumed on a daily basis. The amount of enzyme decomposition products of defatted microalgae in such health functional foods cannot be uniformly regulated depending on the type of health functional food to be targeted, but can be added within the range that does not damage the original taste of the food. It is usually in the range of 0.01 to 50% by weight, preferably 0.1 to 20% by weight. In addition, in the case of health functional foods in the form of pills, granules, tablets or capsules, it is usually added in the range of 0.1 to 100% by weight, preferably 0.5 to 80% by weight. In one embodiment, the health functional food of the present invention may be in the form of a pill, tablet, capsule or beverage.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, a preferred embodiment is presented to aid in the understanding of the present invention, but it is obvious to those skilled in the art that various changes and modifications are possible within the scope of the present invention and the scope of the technical idea, but the following examples are only illustrative of the present invention, It is natural that such modifications and modifications fall within the scope of the appended claims.
제조예 1. 단백질 분해효소Preparation Example 1. Proteolytic enzyme
발효 식품 유래 단백질 분해효소 균주의 분리Isolation of proteolytic enzyme strains derived from fermented foods
단백질 분해능이 우수한 균주 분리를 위해 전국 18개 지역의 전통식품 제조업체로부터 2017년에 제조된 청국장을 구매하여 배양과정을 거쳐 단백질 분해효소 활성이 우수한 균주를 분리하여 사용하였다. 구입한 청국장 시료 1 g을 멸균 증류수에 20 ml에 현탁하고 상온에서 20분간 200 rpm에서 교반하여 현탁액을 MRS 고체 배지에 도말하여 35 ℃에서 48시간 동안 배양하여 얻은 단일 균체를 확보하였다. 단일 균체를 MRS 액체배지에 접종하고 37 ℃에서 24시간 동안 배양하여 효소분해를 위한 종균으로 사용하였다. 이후, 건조 탈지미세조류를 LB배지 대비 1:20 비율 (w/v)로 첨가하고 종균을 LB 배지 대비 1% (v/v) 접종하여 50 ℃에서 72시간 동안 효소분해를 진행하였다. 효소분해 72시간에서 단백질 분해효소 활성측정을 위해 1 ml의 상등액을 취하여 원심분리를 이용하여 고형분을 원심분리(10,000ㅧg, 20분, 4 ℃)를 통해 제거하고 조효소액을 분리하여 효소활성을 측정하였다. 조효소액의 단백질 분해 활성을 변형된 Kunitz method로 측정하여 단백질분해활성이 가장 높은 균주를 선발하였다.In order to isolate strains with excellent proteolytic ability, Cheonggukjang, manufactured in 2017, was purchased from traditional food manufacturers in 18 regions nationwide, and strains with excellent protease activity were isolated and used through a cultivation process. 1 g of the purchased Cheonggukjang sample was suspended in 20 ml of sterile distilled water and stirred at 200 rpm for 20 minutes at room temperature. The suspension was spread on MRS solid medium and cultured at 35° C. for 48 hours to obtain single cells obtained. Single cells were inoculated into MRS liquid medium and cultured at 37° C. for 24 hours to be used as a seed for enzymatic digestion. Thereafter, dry skim microalgae was added at a ratio of 1:20 (w/v) to the LB medium, and the seed was inoculated with 1% (v/v) compared to the LB medium, followed by enzymatic digestion at 50° C. for 72 hours. At 72 hours of enzymatic digestion, 1 ml of supernatant is taken to measure the protease activity, and the solid content is removed through centrifugation (10,000 xg, 20 minutes, 4 ℃), and the enzyme activity is measured by separating the crude enzyme solution. It was measured. The proteolytic activity of the crude enzyme solution was measured by the modified Kunitz method, and the strain with the highest proteolytic activity was selected.
단백질 분해효소 생산 균주 동정Identification of protease-producing strains
상기에서 분리한 균주를 동정하기 위해 단일 균체를 MRS 고체배지로부터 회수하였으며, 16S rDNA sequencing에 사용하는 universal primer인 27F(S'-AGAGTTTGATCATGGCTCAG-T)와 1492R(5'-GGATACCTTGTTACGACTT-3') primer를 사용하여 PCR 증폭하였다. PCR 산물은 1% 아가로스 겔(5 ㎕, X-gal 30 mg/ml)에서 전기영동한 후 밴드를 확인한 다음 증폭이 확인된 PCR 산물을 코스모진텍(주)에 의뢰하여 동정하였다.To identify the strain isolated above, a single cell was recovered from the MRS solid medium, and the universal primers 27F (S'-AGAGTTTGATCATGGCTCAG-T) and 1492R (5'-GGATACCTTGTTACGACTT-3') primers used for 16S rDNA sequencing were used. PCR amplification was performed using. The PCR product was electrophoresed on a 1% agarose gel (5 µl, X-gal 30 mg/ml), the band was checked, and then the PCR product with amplification was confirmed by requesting Cosmo Genetech Co., Ltd. to identify it.
구체적으로, 전통 발효방식으로 제조된 청국장을 구입하여 균주의 colony 형태에 따라 총 18종 분리하였으며 각 균주를 skim milk plate에 접종하여 clear zone을 형성하는 균을 1차 분리하였다. 청국장에서 분리한 균주 중 18번 균주에서 clear zone이 가장 명확하게 확인되었다(도 1). 분리균주의 단백질 분해효소 활성을 측정하였을 때, 12종 균주에서 단백질분해 활성이 보였으며 18번 균주에서 가장 높은 95.9 unit/ml의 활성을 보여 1차 선정결과와 동일한 결과를 얻었다(도 2). 선발된 18번 균주의 16S rDNA 염기서열을 분석한 결과 Bacillus sp.으로 나타났으며 Bacillus 표준 종들과의 상동성을 조사한 결과 바실러스 테퀼엔시스(B. tequilensis)와 높은 상동성을 갖는 균주로 확인되어 이를 바실러스 테퀼엔시스(B. tequilensis) SM18(서열번호 1)이라 명명하고 생물자원센터(KCTC)에 기탁하였다. Specifically, Cheonggukjang prepared by the traditional fermentation method was purchased, and a total of 18 species were separated according to the colony type of the strain. Each strain was inoculated into a skim milk plate to first isolate the bacteria forming a clear zone. Of the strains isolated from Cheonggukjang, the clear zone was most clearly identified in strain 18 (FIG. 1). When the proteolytic enzyme activity of the isolated strains was measured, proteolytic activity was observed in 12 strains, and the highest activity was 95.9 unit/ml in
종균을 이용하여 단백질 분해효소가 포함된 조효소액 생산을 위해 단백질 생산용으로 최적화를 완료한 생산배지인 LB 배지를 사용하였다. 상기 최적화 생산배지의 성분은 LB 배지에 3% 콩추출액, fructose 2.1%, beef extract 2.25%를 추가한 것으로 종균 0.5 ml을 50 ml의 생산배지에 접종하고 37 ℃에서 72시간 동안 200 rpm 조건으로 배양한 뒤, 원심분리(10,000Xg, 20분, 4 ℃)하여 상등액을 회수하여 탈지미세조류단백질 분해를 위한 조효소액으로 사용하였다
In order to produce a crude enzyme solution containing protease using the seed, LB medium, a production medium optimized for protein production, was used. The components of the optimized production medium were 3% soybean extract, 2.1% fructose, and 2.25% beef extract added to the LB medium. 0.5 ml of the seed was inoculated into 50 ml of the production medium and cultured at 200 rpm for 72 hours at 37°C. After that, the supernatant was collected by centrifugation (10,000Xg, 20 minutes, 4℃) and used as a crude enzyme solution for decomposing defatted microalgae protein.
실시예 1. 청국장 유래 단백질 분해효소 이용Example 1. Use of proteolytic enzyme derived from Cheonggukjang
탈지미세조류Skim microalgae
탈지미세조류는 인하대학교 해양바이오연구센터로부터 실내 배양기에서 배양 후 탈지과정을 마친 Tetraselmis KCTC 12236BP를 제공받았으며, 시료는 60 ℃ 열풍건조기에서 24시간 건조 후 -18 ℃에서 냉장 보관하여 사용하였다. Degreasing microalgae was provided with Tetraselmis KCTC 12236BP, which had been cultivated in an indoor incubator and then degreased, from Inha University's Marine Bio Research Center. Samples were dried in a hot air dryer at 60° C. for 24 hours and stored in a refrigerator at -18° C.
효소가수분해Enzyme hydrolysis
탈지미세조류 단백질의 효소 분해를 위해 탈지미세조류와, 상기 제조예 1에서 기탁된 단백질 분해효소(B. tequilensis SM18)를 배양하여 얻은 상등액(조효소액)을 고액비 1:20(w/v)으로 혼합한 후 진탕배양기에서 50 ℃, 200 rpm에서 72시간 동안 효소분해 진행하였다. 반응 중지를 위해 100 ℃의 물에서 10분간 가열하여 효소를 불활성화 시키고 20분간 원심분리(3000Xg)를 하여 얻어진 상등액을 회수하여 실험에 사용하였다.
The supernatant (coenzyme solution) obtained by culturing the skim microalgae and the proteolytic enzyme (B. tequilensis SM18 ) deposited in Preparation Example 1 for enzymatic decomposition of the skim microalgal protein was mixed with a high-liquid ratio of 1:20 (w/v) After mixing in a shaking incubator, enzymatic digestion was carried out at 50° C. and 200 rpm for 72 hours. To stop the reaction, the enzyme was inactivated by heating in water at 100° C. for 10 minutes, and the supernatant obtained by centrifugation (3000Xg) for 20 minutes was recovered and used in the experiment.
비교예 1. 알칼라아제(Alcalase) 단백질 분해효소 이용Comparative Example 1. Use of Alcalase Proteolytic Enzyme
상기 실시예 1과 동일하게 실시하되, 단백질 분해효소로 B. tequilensis SM18 대신 알칼라아제(Novozyme A/S사)를 제공받아 완충용액 대비 200배 희석하여 효소액으로 사용함으로써 탈지미세조류 효소분해물을 수득하였다.
In the same manner as in Example 1, but instead of B. tequilensis SM18 as a proteolytic enzyme, an alcalase (Novozyme A/S) was provided, diluted 200 times compared to a buffer solution, and used as an enzyme solution to obtain an enzyme digestion of skim microalgae. I did.
비교예 2. 프로타맥스(Protamax) 단백질 분해효소 이용Comparative Example 2. Using Protamax proteolytic enzyme
상기 실시예 1과 동일하게 실시하되, 단백질 분해효소로 B. tequilensis SM18 대신 프로타맥스(Novozyme A/S사)를 제공받아 완충용액 대비 200배 희석하여 효소액으로 사용함으로써 탈지미세조류 효소분해물을 수득하였다.
Conducted in the same manner as in Example 1, except that Protamax (Novozyme A/S) was provided instead of B. tequilensis SM18 as a proteolytic enzyme, diluted 200 times compared to the buffer solution, and used as an enzyme solution to obtain an enzyme digestion of skim microalgae. I did.
비교예 3. 뉴트라제(Neutrase) 단백질 분해효소 이용Comparative Example 3. Nutrase (Neutrase) using proteolytic enzyme
상기 실시예 1과 동일하게 실시하되, 단백질 분해효소로 B. tequilensis SM18 대신 뉴트라제(Novozyme A/S사)를 제공받아 완충용액 대비 200배 희석하여 효소액으로 사용함으로써 탈지미세조류 효소분해물을 수득하였다.
In the same manner as in Example 1, but instead of B. tequilensis SM18 as a proteolytic enzyme, Nutrase (Novozyme A/S) was provided, diluted 200 times compared to the buffer solution, and used as an enzyme solution, thereby obtaining an enzyme lysate of skim microalgae. .
비교예 4. 플라보르자임(Flavourzyme) 단백질 분해효소 이용Comparative Example 4. Flavorzyme Proteolytic Enzyme Use
상기 실시예 1과 동일하게 실시하되, 단백질 분해효소로 Bacillus tequilensis SM18 대신 플라보르자임(Novozyme A/S사)를 제공받아 완충용액 대비 200배 희석하여 효소액으로 사용함으로써 탈지미세조류 효소분해물을 수득하였다.
In the same manner as in Example 1, but instead of Bacillus tequilensis SM18 as a proteolytic enzyme, flavorzyme (Novozyme A/S) was provided, diluted 200 times compared to the buffer, and used as an enzyme solution, thereby obtaining an enzyme digestion of skim microalgae. .
비교예Comparative example 5. 5. 열수Hydrothermal 분해 decomposition
상기 실시예 1의 탈지미세조류 1 g에 증류수 20 mL을 가하여 진탕배양기(SIB-05RH, Jeongbio, Korea)에서 80 ℃, 200 rpm으로 16시간 동안 추출을 진행하여 탈지미세조류 열수분해물을 수득하였다.
20 mL of distilled water was added to 1 g of the defatted microalgae of Example 1, and extraction was performed in a shaking incubator (SIB-05RH, Jeongbio, Korea) at 80° C. and 200 rpm for 16 hours to obtain a hydrolyzed product of the defatted microalgae.
비교예 6. 1 M HComparative Example 6. 1 M H 22 SOSO 4 4 이용한 가수분해Hydrolysis using
강산을 이용한 단백질 분해는 탈지미세조류와 1 M H2SO4를 고액비 1:20(w/v)으로 혼합한 후 sand bath(CSB2, Sungwong Science, Korea)를 이용하여 110 ℃에서 24시간 반응 후 CaCO3로 중화하여 탈지미세조류 화학적 분해물을 수득하였다.
Protein decomposition using strong acid was carried out by mixing degreasing microalgae and 1 MH 2 SO 4 in a high-liquid ratio of 1:20 (w/v), and then reacting at 110° C. for 24 hours using a sand bath (CSB2, Sungwong Science, Korea). Neutralization with CaCO 3 gave a chemical decomposition product of defatted microalgae.
비교예 7. 6 M HClComparative Example 7. 6 M HCl 이용한 가수분해Hydrolysis using
상기 비교예 6과 동일하게 실시하되, 1 M H2SO4 대신 6 M HCl을 이용하여 탈지미세조류 화학적 분해물을 수득하였다.
In the same manner as in Comparative Example 6, a chemical decomposition product of defatted microalgae was obtained using 6 M HCl instead of 1 MH 2 SO 4.
비교예 8. 1 M NaOH 이용한 가수분해Comparative Example 8. Hydrolysis using 1 M NaOH
염기를 이용한 단백질 분해는 탈지미세조류과 1 M NaOH를 고액비 1:20(w/v)으로 혼합한 후 sand bath(CSB2, Sungwong Science, Korea)를 이용하여 110 ℃에서 24시간 반응시킨 다음 상온에서 냉각하여 원심분리(3000ㅧg, 20분)로 상등액을 회수하여 탈지미세조류 화학적 분해물을 수득하였다.
Protein decomposition using a base was carried out by mixing skim microalgae and 1 M NaOH in a high-liquid ratio of 1:20 (w/v), and then reacting at 110° C. for 24 hours using a sand bath (CSB2, Sungwong Science, Korea), and then at room temperature. After cooling, the supernatant was recovered by centrifugation (3000 xg, 20 minutes) to obtain a chemical decomposition product of defatted microalgae.
<시험예><Test Example>
시험예 1. 일반성분 분석Test Example 1. General component analysis
시료의 일반성분 함량은 식품공전에 따라 분석하였다. 수분은 105 ℃의 건조기에서 상압가열 건조법으로 분석하였고 회분은 550 ℃ 회화로에서 직접 회화하여 중량법으로 분석하였다 조단백질은 Kjeldahl 분해법으로 분석한 후 질소계수 6.25를 곱하여 퍼센트 함량(w/w)으로 표시하였다. 조지방은 Soxhlet 추출법을 이용하여 시료에 함유된 조지방을 ether로 추출하여 측정하였다. 수분을 제외한 모든 성분은 수분보정을 거쳐 건조중량(dry weight basis) 기준으로 환산하여 미세조류의 탈지 전과 후의 성분 함량을 비교하였다. 탄수화물은 다음 공식에 의하여 계산한 후 건조중량으로 환산하였다. 탄수화물은 셀룰로오스와 헤미셀룰로오스의 함량을 기반으로 각 당 성분의 함량은 미국 신재생에너지연구소(NREL; National Renewable Energy Laboratory)의 표준 분석법(NREL Laboratory Analytical Procedures)에 따라 분석하였다.The content of general components of the sample was analyzed according to the food code. Moisture was analyzed by atmospheric pressure drying method in a drying machine at 105°C, and ash was directly incinerated in an incinerator at 550°C and analyzed by gravimetric method. Crude protein was analyzed by Kjeldahl decomposition method and then multiplied by a nitrogen coefficient of 6.25 and expressed as percent content (w/w) . Crude fat was measured by extracting the crude fat contained in the sample with ether using the Soxhlet extraction method. All components except moisture were converted on a dry weight basis through moisture correction, and the content of components before and after degreasing of microalgae was compared. Carbohydrates were calculated by the following formula and converted into dry weight. Carbohydrates were analyzed based on the content of cellulose and hemicellulose, and the content of each sugar component was analyzed according to the NREL Laboratory Analytical Procedures of the National Renewable Energy Laboratory (NREL).
위 표 1에 나타낸 바와 같이, 탈지된 미세조류는 탈지 전의 미세조류에 비하여 조지방의 함량은 현저히 낮아졌으며, 조단백질의 함량은 높아진 것을 확인하였다.
As shown in Table 1 above, it was confirmed that the content of crude fat was significantly lower in the degreasing microalgae compared to the microalgae before degreasing, and the content of crude protein was increased.
시험예 2. 전기영동 측정Test Example 2. Electrophoresis measurement
도 3은 비교예 5 내지 8에 따라 화학적 가수분해에 따른 단백질 분자량의 변화를 확인하기 위하여 SDS-PAGE를 이용함으로써 단백질 분자량을 비교한 것이며; 도 4는 비교예 1 내지 4에 따라 시판용 효소를 이용한 효소적 가수분해에 따른 단백질 분자량의 변화를 확인하기 위하여 SDS-PAGE를 이용함으로써 단백질 분자량을 비교한 것이고; 도 5는 실시예 1 및 비교예 1에 따라 상이한 효소를 사용 시 효소적 가수분해에 따른 단백질 분자량의 변화를 확인하기 위하여 SDS-PAGE를 이용함으로써 단백질 분자량을 비교한 것이다.3 is a comparison of protein molecular weights by using SDS-PAGE to confirm the change in protein molecular weight due to chemical hydrolysis according to Comparative Examples 5 to 8; 4 is a comparison of protein molecular weights by using SDS-PAGE to confirm the change in protein molecular weight due to enzymatic hydrolysis using commercially available enzymes according to Comparative Examples 1 to 4; 5 is a comparison of protein molecular weights by using SDS-PAGE in order to confirm the change in protein molecular weight due to enzymatic hydrolysis when using different enzymes according to Example 1 and Comparative Example 1. FIG.
전기영동은 Laemmli의 방법에 따라 sodium dodecyl sulfate-polyacrylamide gel electrophoresis(SDS-PAGE)를 이용하여 분자량을 측정하였다. 분자량 6.5~200 kDa의 펩타이드 확인을 위해 12% SDS polyacrylamide gel과 1.4~26.6 kDa의 분자량의 분포를 확인하기 위해 15% SDS polyacrylamide gel을 사용하였다. Staining buffer는 0.1% coomassie brilliant blue R-250, 45% methanol and 10% acetic acid을 혼합하여 사용하고, destaining buffer는 10% acetic acid과 45% methanol을 혼합하여 사용하였다. 분자량 측정을 위한 marker로 SDS-PAGE molecular weight standards(Biorad, USA)를 사용하였다. 펩타이드 분자량 재확인을 위해 MALDI-TOF-MS 분석을 진행하였으며 Smartbeam-II laser TYPE이 장착된 Autoflex speed TOF/TOF(Bruker MA, USA) 모델을 이용하여 positive linear mode에서 펩타이드 분자량을 측정하였다. Electrophoresis was performed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli's method. A 12% SDS polyacrylamide gel and a 15% SDS polyacrylamide gel were used to check the molecular weight distribution of 1.4 to 26.6 kDa to identify peptides with a molecular weight of 6.5 to 200 kDa. The staining buffer was used by mixing 0.1% coomassie brilliant blue R-250, 45% methanol and 10% acetic acid, and the destaining buffer was used by mixing 10% acetic acid and 45% methanol. SDS-PAGE molecular weight standards (Biorad, USA) were used as a marker for molecular weight measurement. To reconfirm the peptide molecular weight, MALDI-TOF-MS analysis was performed, and the peptide molecular weight was measured in positive linear mode using an Autoflex speed TOF/TOF (Bruker MA, USA) model equipped with a Smartbeam-II laser TYPE.
여러 가지 단백질 분해방법이 탈지미세조류 펩타이드 생산에 미치는 영향을 비교하기 위해 열수분해, 화학적 분해, 상업효소 및 B. tequilensis SM18를 이용한 단백질 분해를 진행하였다. In order to compare the effects of various proteolytic methods on the production of skim microalgae peptides, hydrolysis, chemical digestion, commercial enzymes, and protein digestion using B. tequilensis SM18 were performed.
화학적 분해에 의한 펩타이드 생산Peptide production by chemical degradation
도 3에 도시된 바와 같이, 비교예 5와 같이 단백질을 열수분해시킨 경우에는 3.4, 5.5 및 6.5 kDa 부근에서 밴드를 확인함으로써 탈지미세조류의 수용성 단백질이 3종류의 분자량을 가짐을 확인하였다. As shown in FIG. 3, when the protein was hydrolyzed as in Comparative Example 5, bands were observed around 3.4, 5.5, and 6.5 kDa to confirm that the water-soluble protein of skim microalgae had three types of molecular weight.
반면, 비교예 6 내지 8과 같은 염기 또는 산 분해의 경우에는 1.4-200 kDa 사이에 밴드가 분포하지 않으므로 탈지미세조류 단백질이 1.4 kDa 이하의 펩타이드로 분해됨을 확인하였다. On the other hand, in the case of base or acid degradation as in Comparative Examples 6 to 8, since the band was not distributed between 1.4-200 kDa, it was confirmed that the skim microalgal protein was degraded into a peptide of 1.4 kDa or less.
상업용 효소 분해에 의한 펩타이드 생산Peptide production by commercial enzymatic digestion
대조군으로는 sodium phosphate buffer를 사용하여 단백질 분해조건과 동일한 조건에서 펩타이드 추출을 진행하였다.As a control, a sodium phosphate buffer was used to extract peptides under the same conditions as those for protein degradation.
도 4에 도시된 바와 같이, 대조군은 16~26.6 kDa 사이에서 분해된 펩타이드 밴드가 확인되었으며, 비교예 3 및 비교예 4에서도 대조군과 동일한 펩타이드 분자량이 확인되어 뉴트라제와 플라보르자임에 의해 탈지미세조류 단백질이 분해되지 않음을 알 수 있었다. As shown in Figure 4, the control group was confirmed to be a peptide band decomposed between 16 ~ 26.6 kDa, Comparative Example 3 and Comparative Example 4 also confirmed the same peptide molecular weight as the control group, degreasing microscopically by neutrase and flavorzyme It was found that the algal protein was not degraded.
반면, 비교예 1 및 비교예 2에서는 대조군에 밴드가 확인되지 않아 탈지미세조류 단백질이 1.4 kDa 이하의 펩타이드로 분해되었음을 예측할 수 있었다. 일반적으로 단백질을 단일 아미노산으로 분해시킨다고 알려진 6 M HCl을 이용한 산 분해와 유사한 SDS-PAGA 결과 보여줬는데 이는 상업효소인 프로타맥스와 알카라아제가 탈지미세조류 단백질의 강산 및 강염기를 이용한 화학분해와 같이 저분자 펩타이드로 분해시키는데 매우 효과적인 효소임을 보여준다. On the other hand, in Comparative Examples 1 and 2, the band was not identified in the control group, so it could be predicted that the skim microalgal protein was degraded into a peptide of 1.4 kDa or less. In general, SDS-PAGA results similar to acid digestion using 6 M HCl, which is known to degrade proteins into single amino acids, showed that commercial enzymes, Protamax and Alkalase, were used for chemical degradation using strong acids and strong bases of defatted microalgae proteins. Likewise, it shows that it is a very effective enzyme for decomposing into small molecular peptides.
B. tequilensis B. tequilensis SM18 효소 분해에 의한 펩타이드 생산Peptide production by SM18 enzyme digestion
도 5에 도시된 바와 같이, 탈지미세조류 단백질 분해를 통한 미백과 피부재생 효과를 가지는 기능성 펩타이드 생산을 위해 상기 제조예 1에서 분리한 B. tequilensis SM18의 조효소액을 이용하여 탈지미세조류 단백질 분해를 시도하여 SDS-PAGE를 이용하여 분해여부를 확인하였다. As shown in Figure 5, for the production of functional peptides having whitening and skin regeneration effects through decomposition of skim microalgae, protein decomposition of skim microalgae was performed using the coenzyme solution of B. tequilensis SM18 isolated in Preparation Example 1 above. Attempts were made to confirm whether they were degraded using SDS-PAGE.
열수분해물은 상기 도 3의 SDS-PAGE 결과와 동일하게 3.4, 5.5와 6.5 kDa 부근에서 밴드를 확인하였다. 기질이 포함되지 않은 효소액의 단백질 분자량을 확인한 결과 알카레이즈는 모든 분자량에서 밴드가 나타나지 않았으며, 알카레이즈 가수분해물인 비교예 1에서는 상기 도 4의 결과와 동일하게 탈지미세조류 단백질이 1.4 kda 이하로 분해됨을 확인하였다. As for the hydrolyzed product, bands were identified around 3.4, 5.5 and 6.5 kDa as in the SDS-PAGE result of FIG. 3. As a result of confirming the protein molecular weight of the enzyme solution containing no substrate, alkarease did not show a band at all molecular weights, and in Comparative Example 1, which is an alkalase hydrolyzate, the defatted microalgal protein was 1.4 kda or less as in the result of FIG. 4. It was confirmed that it was degraded.
B. tequilensis SM18의 조효소액을 이용한 실시예 1의 탈지미세조류 효소분해물에서도 비교예 1의 결과와 같이 대조군의 3개의 밴드가 확인되지 않아 탈지미세조류 단백질이 분해되었다는 것을 확인되어 청국장 유래 B. tequilensis SM18에 의해 생산된 단백질 분해효소(조효소액)가 상업효소를 대체할 수 있는 가능성을 확인하였다. As in the result of Comparative Example 1, it was confirmed that the skim microalgal protein was degraded because the three bands of the control group were not identified in the enzyme decomposition product of skim microalgae of Example 1 using the crude enzyme solution of B. tequilensis SM18. It was confirmed that the proteolytic enzyme (coenzyme solution) produced by SM18 could replace commercial enzymes.
본 발명의 B. tequilensis SM18의 조효소에 의해 분해된 탈지미세조류 단백질의 분자량의 확인을 위해 MALDI-TOF를 이용하여 펩타이드 분포를 확인하였으며, SDS-PAGE에서 확인한 바와 같이 탈지미세조류 단백질이 1.4 kDa이하 펩타이드로 분해되었음을 확인하였으며, 분해 펩타이드는 655 da, 890 da과 1,003 da으로 각각 존재함을 확인하여 B. tequilensis SM18에 의해 생산된 펩타이드가 모두 9개 이하의 아미노산의 결합으로 이루어짐을 확인하였다.
B. tequilensis of the present invention To confirm the molecular weight of the skim microalgal protein degraded by the coenzyme of SM18, the distribution of the peptide was confirmed using MALDI-TOF, and as confirmed by SDS-PAGE, it was confirmed that the skim microalgal protein was degraded into a peptide of 1.4 kDa or less. , It was confirmed that the degraded peptides were 655 da, 890 da and 1,003 da, respectively, and it was confirmed that all of the peptides produced by B. tequilensis SM18 consist of a combination of 9 or less amino acids.
시험예 3. 단백질 분해효소의 활성 측정Test Example 3. Measurement of proteolytic enzyme activity
단백질 분해효소를 이용한 탈지미세조류 가수분해를 통한 펩타이드 생산에 앞서 각 효소의 단백질 가수분해능을 확인하기 위해 효소활성을 측정하였다.Prior to the production of peptides through hydrolysis of skim microalgae using a proteolytic enzyme, enzyme activity was measured to confirm the proteolytic ability of each enzyme.
단백질 분해효소 활성 측정 실험은 Kim 등의 방법을 변형하여 수행하였다. 50 mM sodium phosphate buffer에 0.6% casein을 첨가하여 사용하였으며, 각 효소 희석액 또는 조효소액 0.25 mL을 0.6% casein에 첨가하고 37 ℃에서 10분간 반응을 진행시킨 후 0.44 mol trichloroacetic acid을 첨가하여 효소반응을 정지시켰다. 반응이 정지된 시료액을 원심분리하여 얻은 상등액 0.4 mL에 Na2CO3 1 mL과 Folin & Ciocalteu's 페놀용액 0.2 mL을 첨가하고 30분간 반응을 진행시킨 후 660 nm에서 분광분석기(UV-1650PC, Shimadzu, Kyoto, Japan)로 흡광도를 측정하였다. Tyrosine을 표준물질로 사용하여 표준국선을 작성하여 단백질 활성을 환산하여 표시하였다. The experiment for measuring protease activity was performed by modifying the method of Kim et al. 0.6% casein was added to 50 mM sodium phosphate buffer, and 0.25 mL of each enzyme dilution or coenzyme solution was added to 0.6% casein, and the reaction was allowed to proceed at 37°C for 10 minutes, and then 0.44 mol trichloroacetic acid was added to perform the enzyme reaction. Stopped. 1 mL of Na 2 CO 3 and 0.2 mL of Folin &Ciocalteu's phenol solution were added to 0.4 mL of the supernatant obtained by centrifuging the sample solution where the reaction was stopped, and the reaction was allowed to proceed for 30 minutes, followed by a spectroscopic analyzer (UV-1650PC, Shimadzu) at 660 nm. , Kyoto, Japan) to measure the absorbance. Using Tyrosine as a standard material, a standard trunk line was prepared and the protein activity was converted and displayed.
위 표 2에 나타낸 바와 같이, 상업효소 4종의 단백질 분해효소 활성은 플라보르자임 < 뉴트라아제 < 프로타맥스 = 알카라아제 순으로 측정되었는데 이는 앞선 SDS-PAGE 실험에서 알카라아제와 프로타맥스가 플라보르자임와 뉴트라아제에 비해 펩타이드 분해가 우수했다는 것이 높은 효소 활성이 기인한다는 것으로 보여준다. As shown in Table 2 above, the protease activity of four commercial enzymes was measured in the order of flavorzyme <neutraase <protamax = alkalase, which was measured in the order of alkaline enzyme and protamax in the previous SDS-PAGE experiment. It was shown that the high enzyme activity was attributed to the superior peptide degradation compared to flavorzyme and neutraase.
B. tequilensis SM18를 생산배지를 이용하여 72시간 배양하였을 때, 단백질 분해효소 활성이 427.6 unit/mL로 측정되어 알카라아제의 활성인 372.9 unit/mL에 비해 높은 것으로 확인되었다.
When B. tequilensis SM18 was cultured for 72 hours using the production medium, the protease activity was measured to be 427.6 unit/mL, which was confirmed to be higher than that of the alkaline enzyme, 372.9 unit/mL.
시험예 4. 타이로시네이즈(Tyrosinase) 및 콜라게네이즈(Collagenase) 저해활성 측정Test Example 4. Measurement of tyrosinase and collagenase inhibitory activity
4-1. 타이로시네이즈 저해활성 측정은 Yagi 등의 방법에 따라 측정하였다. sodium phosphate buffer(67 mM, pH 6.8) 0.4 mL와 3,4-dihydroxy phenylalanine(10 mM, L-DOPA)용액 0.2 mL를 혼합하고 mushroom tyrosinase(125 unit/mL) 0.1 mL와 시료 0.2 mL를 첨가하고 37 ℃에서 20 분간 반응시킨 후 분광분석기로 475 nm에서 흡광도를 측정하였다. 4-1. The measurement of tyrosinase inhibitory activity was measured according to the method of Yagi et al. Mix 0.4 mL of sodium phosphate buffer (67 mM, pH 6.8) and 0.2 mL of 3,4-dihydroxy phenylalanine (10 mM, L-DOPA) solution, and add 0.1 mL of mushroom tyrosinase (125 unit/mL) and 0.2 mL of sample. After reacting at 37° C. for 20 minutes, absorbance was measured at 475 nm with a spectrometer.
[수학식 1][Equation 1]
타이로시네이즈 활성 저해율(%)=(1-시료첨가군/시료 미첨가군)X100Tyrosinase activity inhibition rate (%) = (1-sample added group/sample not added group) X100
멜라닌은 자외선을 차단하여 피부를 보호하는 이로운 작용을 하나 과도한 멜라닌 생성은 기미, 주근깨 및 피부 흑화의 원인이 되며 피부 노화와 피부암을 유발하는 것으로 알려져 있다. 타이로시네이즈는 멜라닌 합성 단계에서 중요한 역할을 하는 효소로 타이로시네이즈 활성 증가에 따라 타이로신이 DOPA로 전환되어 멜라닌 생성이 증가한다고 알려져 있어 피부 미백을 위해서는 타이로시네이즈 활성 저해가 필수적이다. Melanin has a beneficial effect of protecting the skin by blocking ultraviolet rays, but excessive melanin production causes spots, freckles and skin blackening, and is known to cause skin aging and skin cancer. Tyrosinase is an enzyme that plays an important role in the melanin synthesis step, and it is known that tyrosine is converted to DOPA as tyrosinase activity increases, thereby increasing melanin production. Therefore, inhibition of tyrosinase activity is essential for skin whitening.
4-2. 콜라게네이즈 저해활성 측정은 Wunsh와 Heindrich의 방법에 따라 수행하였다. Tris-HCl buffer(0.1 M, pH 7.5)에 4 mM CaCl₂를 첨가하고 4-phenylazobenzyl oxycarbonyl-Pro-Leu-Gly-Pro-D-Arg(0.3 mg/mL)을 기질로 사용하였다. 기질 0.125 mL와 시료 0.05 mL을 혼합하고 콜라게네이즈(Clostridium histolyticum, 1 mg/mL) 0.075 mL를 첨가하여 실온에서 20분간 방치한 후 6% citric acid 0.5 mL를 넣어 반응을 정지시켰다. 이후 ethyl acetate 2 mL을 첨가하여 분광분석기로 320 nm에서 흡광도를 측정하였다.4-2. The measurement of collagenase inhibitory activity was performed according to the method of Wunsh and Heindrich. 4 mM CaCl₂ was added to Tris-HCl buffer (0.1 M, pH 7.5), and 4-phenylazobenzyl oxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (0.3 mg/mL) was used as a substrate. 0.125 mL of the substrate and 0.05 mL of the sample were mixed, 0.075 mL of collagenase (Clostridium histolyticum, 1 mg/mL) was added, left at room temperature for 20 minutes, and 0.5 mL of 6% citric acid was added to stop the reaction. Then, 2 mL of ethyl acetate was added and the absorbance was measured at 320 nm with a spectrometer.
[수학식 2] [Equation 2]
콜라게네이즈 저해율(%)=(1-시료첨가군/시료 미첨가군)X100Collagenase inhibition rate (%) = (1-sample added group/sample not added group) X100
피부 진피는 표피와 피하지방층 사이에 존재하는 결합 조직으로 피부의 탄력성과 장력을 유지하여 표피를 구조적으로 지지하는 역할을 한다. 엘라스틴과 함께 진피층의 주요 구조 단백질인 콜라겐은 노화가 진행됨에 따라 콜라게네이즈의 활성 증가로 분해가 촉진되어 콜라겐 섬유의 길이는 물론 분포가 감소하여 피부노화를 진행시킨다고 알려져 있다. 콜라겐은 결합조직의 저항력과 조직간 결합력 강화, 피부의 견고성 유지 등의 기능성이 있어 화장품 성분으로 많이 이용되며 최근 해양유래 자원의 단백질을 이용한 콜라겐 소재 추출을 통해 피부재생 및 모발치료에 대한 연구가 활발히 진행되고 있다. 주름개선 효과를 확인하기 위해 콜라게네이즈 활성 저해율을 측정한다.The skin dermis is a connective tissue that exists between the epidermis and the subcutaneous fat layer and plays a role of structurally supporting the epidermis by maintaining the elasticity and tension of the skin. It is known that collagen, a major structural protein of the dermal layer along with elastin, accelerates decomposition by increasing the activity of collagenase as aging progresses, reducing the length and distribution of collagen fibers, leading to skin aging. Collagen is widely used as a cosmetic ingredient because it has functions such as strengthening the resistance of connective tissues, strengthening the bonding between tissues, and maintaining the firmness of the skin. It's going on. In order to confirm the effect of improving wrinkles, the rate of inhibition of collagenase activity is measured.
대조군 1은 증류수를 이용하여 효소분해 조건과 동일한 조건에서 탈지미세조류의 펩타이드 추출을 진행한 것이며, 대조군 2는 sodium phosphate buffer를 사용하여 단백질 분해조건과 동일한 조건에서 펩타이드 추출을 진행하였다.In the
위 표 3에 나타낸 바와 같이, 본 발명의 실시예 1에 따라 제조된 탈지미세조류 효소분해물이 다른 군에 비하여 타이로시네이즈 억제능 및 콜라게네이즈 억제능이 우수한 것을 확인하였다. 타이로시네이즈와 콜라게네이즈 활성저해에 있어 B. tequilensis SM18 유래 조효소액이 상업효소인 알카레이즈 보다 높은 저해율을 보였으며, 이는 청국장 유례 B. tequilensis SM18의 조효소액을 이용한 탈지미세조류 단백질 분해를 통해 미백과 피부재생을 위한 화장용 소재 생산에 있어 상업적으로 사용되는 기존 효소보다 효과 우수함을 시사한다.As shown in Table 3 above, it was confirmed that the enzyme decomposition product of skim microalgae prepared according to Example 1 of the present invention has superior tyrosinase inhibitory ability and collagenase inhibitory ability compared to other groups. In the inhibition of tyrosinase and collagenase activity, the coenzyme solution derived from B. tequilensis SM18 showed a higher inhibition rate than that of the commercial enzyme, Alkarease . This suggests that it is more effective than conventional enzymes commercially used in the production of cosmetic materials for whitening and skin regeneration.
반면, 비교예 5의 탈지미세조류 열수분해물에 대한 타이로시네이즈 억제능은 1.3%로 매우 낮았으며, 비교예 6 내지 8의 화학적 분해물 역시 7.4 내지 10.5%로 낮은 것을 확인하였다. 비교예 6 내지 8의 염기 및 산 분해물에 대한 SDS-PAGE 결과에서 단백질이 1.4 kDa 이하로 분해되며 해당 분해조건에서 단백질이 모두 단일 아미노산으로 분해된다고 알려져 있어 타이로시네이즈 활성저해는 단일 아미노산에 의한 저해 효과로 예상할 수 있다. On the other hand, it was confirmed that the tyrosinase inhibitory ability for the degreasing microalgae hydrolyzate of Comparative Example 5 was very low as 1.3%, and the chemical decomposition products of Comparative Examples 6 to 8 were also low as 7.4 to 10.5%. In the SDS-PAGE results for base and acid degradation products of Comparative Examples 6 to 8, the protein is degraded to 1.4 kDa or less, and it is known that all proteins are decomposed into a single amino acid under the corresponding degradation conditions. It can be expected as an inhibitory effect.
6 M HCl을 이용하여 분해한 비교예 6과 알카레이즈를 이용하여 분해한 비교예 1을 비교 시 비교예 1의 타이로시네이즈 억제능이 보다 우수하므로 단일 아미노산 보다는 1.4 kDa 이하의 저분자의 펩타이드로 분해되었을 때 타이로시네이즈 저해활성이 우수하다는 것을 알 수 있다.When comparing Comparative Example 6 digested with 6 M HCl with Comparative Example 1 digested with Alkarease, the tyrosinase inhibitory ability of Comparative Example 1 is more excellent, so it is decomposed into a small molecule peptide of 1.4 kDa or less than a single amino acid. When used, it can be seen that the tyrosinase inhibitory activity is excellent.
또한, 비교예 5의 탈지미세조류 열수분해물에 대한 콜라게네이즈 억제능은 4.1%로 피부재생 효과가 미미할 것으로 사료된다.In addition, the ability to inhibit collagenase against the hydrolyzate of degreasing microalgae in Comparative Example 5 is 4.1%, which is considered to have a slight skin regeneration effect.
타이로시네이즈와 콜라게네이즈 활성 저해에 있어 알카레이즈와 강산(6 mol HCl) 처리를 비교하였을 때, 알카레이즈에 의해 생성된 펩타이드의 타이로시네이즈와 콜라게네이즈 활성저해가 보다 우수함이 확인되었는데, 이는 효소에 의해 생산되는 저분자 펩타이드가 강산에 의해 생산되는 단일 아미노산에 비해 콜라게네이즈 활성저해에 보다 효과적이었기 때문이라 사료된다.
In the inhibition of tyrosinase and collagenase activity, it was confirmed that the inhibition of tyrosinase and collagenase activity of the peptide produced by Alkaraz was more excellent when comparing Alkaraz and strong acid (6 mol HCl) treatment. This is thought to be because the low-molecular peptides produced by enzymes were more effective in inhibiting collagenase activity than single amino acids produced by strong acids.
하기에 본 발명의 분말을 함유하는 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, examples of the formulation of the composition containing the powder of the present invention will be described, but the present invention is not intended to limit it, but is intended to be described in detail.
제제예Formulation example 1. 과립제의 제조 1. Preparation of granules
실시예 1에서 얻은 효소분해물 분말 1,000 mg1,000 mg of the enzyme digestion product powder obtained in Example 1
비타민 혼합물 적량The right amount of vitamin mixture
비타민 A 아세테이트 70 ㎍Vitamin A acetate 70 ㎍
비타민 E 1.0 mg1.0 mg of vitamin E
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mgVitamin B2 0.15 mg
비타민 B6 0.5 mg0.5 mg of vitamin B6
비타민 B12 0.2 ㎍Vitamin B12 0.2 ㎍
비타민 C 10 mg10 mg of vitamin C
비오틴 10 ㎍Biotin 10 ㎍
니코틴산아미드 1.7 mg1.7 mg of nicotinic acid amide
엽산 50 ㎍Folic acid 50 ㎍
판토텐산 칼슘 0.5 mg0.5 mg of calcium pantothenate
무기질 혼합물 적량Suitable amount of inorganic mixture
황산제1철 1.75 mgFerrous sulfate 1.75 mg
산화아연 0.82 mgZinc oxide 0.82 mg
탄산마그네슘 25.3 mgMagnesium carbonate 25.3 mg
제1인산칼륨 15 mgPotassium monophosphate 15 mg
제2인산칼슘 55 mg
구연산칼륨 90 mg90 mg of potassium citrate
탄산칼슘 100 mg100 mg of calcium carbonate
염화마그네슘 24.8 mgMagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 과립제에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 과립제 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능식품 조성물 제조에 사용할 수 있다.
The composition ratio of the vitamin and mineral mixture is relatively suitable for granules, but it is also possible to arbitrarily modify the mixing ratio. After mixing the above ingredients according to a conventional granule preparation method, granules And can be used to prepare a health functional food composition according to a conventional method.
제제예 2. 기능성 음료의 제조Formulation Example 2. Preparation of functional beverage
실시예 1에서 얻은 효소분해물 분말 1,000 mg1,000 mg of the enzyme digestion product powder obtained in Example 1
구연산 1,000 mg1,000 mg citric acid
올리고당 100 g100 g oligosaccharides
매실농축액 2 g2 g of plum concentrate
타우린 1 g1 g taurine
정제수를 가하여 전체 900 mL900 mL total by adding purified water
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1 시간 동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 L 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 기능성 음료 조성물 제조에 사용한다. After mixing the above ingredients according to a normal health drink manufacturing method, stirring and heating at 85°C for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed and sterilized, and then stored in a refrigerator. It is used to prepare the functional beverage composition of the invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.
The composition ratio is a mixture of ingredients suitable for a relatively preferred beverage in a preferred embodiment, but the mixing ratio may be arbitrarily modified according to regional and ethnic preferences such as the demand class, the country of demand, and the purpose of use.
본 발명을 적용하기에 적합한 화장료 조성물의 제조예를 제시하기로 한다.An example of preparing a cosmetic composition suitable for applying the present invention will be presented.
제조예 3: 화장수Preparation Example 3: Lotion
실시예 1의 탈지미세조류 효소분해물을 포함하는 화장료 중 화장수의 제조예는 하기 표 4와 같다.Examples of the preparation of lotion among cosmetics containing the enzyme decomposition product of skim microalgae of Example 1 are shown in Table 4 below.
제조예Manufacturing example 4: 로션 4: lotion
실시예 1의 탈지미세조류 효소분해물을 포함하는 화장료 중 로션의 제조예는 하기 표 5와 같다.Examples of the preparation of lotions among cosmetics containing the enzyme decomposition product of skim microalgae of Example 1 are shown in Table 5 below.
제조예Manufacturing example 5: 영양 크림 5: nourishing cream
실시예 1의 탈지미세조류 효소분해물을 포함하는 화장료 중 영양 크림의 제조예는 하기 표 6과 같다.Examples of the preparation of a nutritional cream among cosmetics containing the enzyme decomposition product of skim microalgae of Example 1 are shown in Table 6 below.
제조예Manufacturing example 6: 에센스 6: essence
실시예 1의 탈지미세조류 효소분해물을 포함하는 화장료 중 에센스의 제조예는 하기 표 7과 같다.Examples of the preparation of the essence in the cosmetic composition containing the enzyme decomposition product of skim microalgae of Example 1 are shown in Table 7 below.
제조예Manufacturing example 7: 마스크 7: mask 팩용For pack 유액 latex
실시예 1의 탈지미세조류 효소분해물을 포함하는 화장료 중 마스크 팩용 유액의 제조예는 하기 표 8과 같다.Examples of the preparation of the emulsion for a mask pack among cosmetics containing the enzyme decomposition product of degreasing microalgae of Example 1 are shown in Table 8 below.
<110> Industry-Academic Cooperation Foundation, Sun Moon University <120> Compositions containing defatted microalgae extract <130> HPC-8930 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1455 <212> RNA <213> Unknown <220> <223> Bacillus tequilensis <400> 1 aaaatggggg gcgtgctaat acatgcaagt cgagcggaca gatgggagct tgctccctga 60 tgttagcggc ggacgggtga gtaacacgtg ggtaacctgc ctgtaagact gggataactc 120 cgggaaaccg gggctaatac cggatggttg tttgaaccgc atggttcaaa cataaaaggt 180 ggcttcggct accacttaca gatggacccg cggcgcatta gctagttggt gaggtaacgg 240 ctcaccaagg caacgatgcg tagccgacct gagagggtga tcggccacac tgggactgag 300 acacggccca gactcctacg ggaggcagca gtagggaatc ttccgcaatg gacgaaagtc 360 tgacggagca acgccgcgtg agtgatgaag gttttcggat cgtaaagctc tgttgttagg 420 gaagaacaag taccgttcga atagggcggt accttgacgg tacctaacca gaaagccacg 480 gctaactacg tgccagcagc cgcggtaata cgtaggtggc aagcgttgtc cggaattatt 540 gggcgtaaag ggctcgcagg cggtttctta agtctgatgt gaaagccccc ggctcaaccg 600 gggagggtca ttggaaactg gggaacttga gtgcagaaga ggagagtgga attccacgtg 660 tagcggtgaa atgcgtagag atgtggagga acaccagtgg cgaaggcgac tctctggtct 720 gtaactgacg ctgaggagcg aaagcgtggg gagcgaacag gattagatac cctggtagtc 780 cacgccgtaa acgatgagtg ctaagtgtta gggggtttcc gccccttagt gctgcagcta 840 acgcattaag cactccgcct ggggagtacg gtcgcaagac tgaaactcaa aggaattgac 900 gggggcccgc acaagcggtg gagcatgtgg tttaattcga agcaacgcga agaaccttac 960 caggtcttga catcctctga caatcctaga gataggacgt ccccttcggg ggcagagtga 1020 caggtggtgc atggttgtcg tcagctcgtg tcgtgagatg ttgggttaag tcccgcaacg 1080 agcgcaaccc ttgatcttag ttgccagcat tcagttgggc actctaaggt gactgccggt 1140 gacaaaccgg aggaaggtgg ggatgacgtc aaatcatcat gccccttatg acctgggcta 1200 cacacgtgct acaatggaca gaacaaaggg cagcgaaacc gcgaggttaa gccaatccca 1260 caaatctgtt ctcagttcgg atcgcagtct gcaactcgac tgcgtgaagc tggaatcgct 1320 agtaatcgcg gatcagcatg ccgcggtgaa tacgttcccg ggccttgtac acaccgcccg 1380 tcacaccacg agagtttgta acacccgaag tcggtgaggt aacctttagg agccagccgc 1440 cgaaaggggg accca 1455 <110> Industry-Academic Cooperation Foundation, Sun Moon University <120> Compositions containing defatted microalgae extract <130> HPC-8930 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1455 <212> RNA <213> Unknown <220> <223> Bacillus tequilensis <400> 1 aaaatggggg gcgtgctaat acatgcaagt cgagcggaca gatgggagct tgctccctga 60 tgttagcggc ggacgggtga gtaacacgtg ggtaacctgc ctgtaagact gggataactc 120 cgggaaaccg gggctaatac cggatggttg tttgaaccgc atggttcaaa cataaaaggt 180 ggcttcggct accacttaca gatggacccg cggcgcatta gctagttggt gaggtaacgg 240 ctcaccaagg caacgatgcg tagccgacct gagagggtga tcggccacac tgggactgag 300 acacggccca gactcctacg ggaggcagca gtagggaatc ttccgcaatg gacgaaagtc 360 tgacggagca acgccgcgtg agtgatgaag gttttcggat cgtaaagctc tgttgttagg 420 gaagaacaag taccgttcga atagggcggt accttgacgg tacctaacca gaaagccacg 480 gctaactacg tgccagcagc cgcggtaata cgtaggtggc aagcgttgtc cggaattatt 540 gggcgtaaag ggctcgcagg cggtttctta agtctgatgt gaaagccccc ggctcaaccg 600 gggagggtca ttggaaactg gggaacttga gtgcagaaga ggagagtgga attccacgtg 660 tagcggtgaa atgcgtagag atgtggagga acaccagtgg cgaaggcgac tctctggtct 720 gtaactgacg ctgaggagcg aaagcgtggg gagcgaacag gattagatac cctggtagtc 780 cacgccgtaa acgatgagtg ctaagtgtta gggggtttcc gccccttagt gctgcagcta 840 acgcattaag cactccgcct ggggagtacg gtcgcaagac tgaaactcaa aggaattgac 900 gggggcccgc acaagcggtg gagcatgtgg tttaattcga agcaacgcga agaaccttac 960 caggtcttga catcctctga caatcctaga gataggacgt ccccttcggg ggcagagtga 1020 caggtggtgc atggttgtcg tcagctcgtg tcgtgagatg ttgggttaag tcccgcaacg 1080 agcgcaaccc ttgatcttag ttgccagcat tcagttgggc actctaaggt gactgccggt 1140 gacaaaccgg aggaaggtgg ggatgacgtc aaatcatcat gccccttatg acctgggcta 1200 cacacgtgct acaatggaca gaacaaaggg cagcgaaacc gcgaggttaa gccaatccca 1260 caaatctgtt ctcagttcgg atcgcagtct gcaactcgac tgcgtgaagc tggaatcgct 1320 agtaatcgcg gatcagcatg ccgcggtgaa tacgttcccg ggccttgtac acaccgcccg 1380 tcacaccacg agagtttgta acacccgaag tcggtgaggt aacctttagg agccagccgc 1440 cgaaaggggg accca 1455
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190130081A KR102260080B1 (en) | 2019-10-18 | 2019-10-18 | Compositions containing defatted microalgae extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190130081A KR102260080B1 (en) | 2019-10-18 | 2019-10-18 | Compositions containing defatted microalgae extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210046412A true KR20210046412A (en) | 2021-04-28 |
KR102260080B1 KR102260080B1 (en) | 2021-06-03 |
Family
ID=75721261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190130081A KR102260080B1 (en) | 2019-10-18 | 2019-10-18 | Compositions containing defatted microalgae extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102260080B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050027080A (en) * | 2001-10-09 | 2005-03-17 | 가부시키가이샤환케루 | Compositions for potentiating glutathione |
KR20120063766A (en) * | 2010-12-08 | 2012-06-18 | 부경대학교 산학협력단 | Microalgae navicula incerta hydrolysate and antioxidant composition comprising same |
KR101305136B1 (en) * | 2011-10-20 | 2013-09-06 | 부경대학교 산학협력단 | Microalga Pavlova lutheri having antioxidative activity fermented by Candida rugopelliculosa, a peptide derived therefrom and health food containing the fermented Pavlova lutheri or the peptide |
KR20170130341A (en) * | 2017-11-20 | 2017-11-28 | 대한민국(농촌진흥청장) | Bacillus amyloliquefacience having antibacterial activity and uses thereof |
KR20190008509A (en) | 2017-07-16 | 2019-01-24 | 김영대 | Development of plant materials having antioxidant and antiaging capacities |
KR20190094326A (en) | 2019-08-02 | 2019-08-13 | 주식회사 엘지생활건강 | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening |
-
2019
- 2019-10-18 KR KR1020190130081A patent/KR102260080B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050027080A (en) * | 2001-10-09 | 2005-03-17 | 가부시키가이샤환케루 | Compositions for potentiating glutathione |
KR20120063766A (en) * | 2010-12-08 | 2012-06-18 | 부경대학교 산학협력단 | Microalgae navicula incerta hydrolysate and antioxidant composition comprising same |
KR101305136B1 (en) * | 2011-10-20 | 2013-09-06 | 부경대학교 산학협력단 | Microalga Pavlova lutheri having antioxidative activity fermented by Candida rugopelliculosa, a peptide derived therefrom and health food containing the fermented Pavlova lutheri or the peptide |
KR20190008509A (en) | 2017-07-16 | 2019-01-24 | 김영대 | Development of plant materials having antioxidant and antiaging capacities |
KR20170130341A (en) * | 2017-11-20 | 2017-11-28 | 대한민국(농촌진흥청장) | Bacillus amyloliquefacience having antibacterial activity and uses thereof |
KR20190094326A (en) | 2019-08-02 | 2019-08-13 | 주식회사 엘지생활건강 | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening |
Also Published As
Publication number | Publication date |
---|---|
KR102260080B1 (en) | 2021-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8088369B2 (en) | Anti-wrinkle agent | |
KR101685581B1 (en) | Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom | |
KR102145447B1 (en) | Cosmetic compositions containing fermented extract of Hippophae rhamnoides L | |
JP2008201773A (en) | External preparation for skin | |
KR20180082056A (en) | A functional cosmetic composition comprising natural complex extract | |
KR101336804B1 (en) | Fermented ear shell using mushroom, manufacturing method thereof and cosmetic composition comprising the same | |
KR102088728B1 (en) | Cosmetic Composition for Improving Skin Elasticity and Winkles Comprising Plant Complex Extracts as Active Ingredient | |
KR101930342B1 (en) | A cosmetic composition | |
KR101804793B1 (en) | Process for producing red sea cucumber-derived peptide powder and cosmetic composition for anti-wrinkle containing the same | |
KR20150144039A (en) | Cosmetic composition containing mushroom extract using magma seawater | |
KR102350857B1 (en) | Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water | |
KR101849885B1 (en) | Cosmetics comprising whey obtained by fermentation with Korean type lactic acid bacteria complex for improving elasticity or moisturizing | |
KR20200064944A (en) | Composition for preventing or improving skin wrinkle containing Glycine max Merrill fermented extract | |
JP2021024805A (en) | External preparation for skin | |
KR102260080B1 (en) | Compositions containing defatted microalgae extract | |
KR101960571B1 (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR102249252B1 (en) | A cosmetic composition comprising microalgae-derived peptide | |
KR102544792B1 (en) | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient | |
KR20190037436A (en) | Cosmetic composition including fermented water lily extract and method for manufacturing the same | |
KR102096444B1 (en) | A cosmetic compositon comprising rice bran protein | |
KR100810006B1 (en) | Soybean ferment extract and cosmetic composition containing the same | |
KR101834153B1 (en) | Process for producing red sea cucumber-derived peptide powder and cosmetic composition for skin whitening containing the same | |
JP2021172593A (en) | External preparation for skin | |
KR101778538B1 (en) | Cosmetic composition comprising ginseng fruit Fermentation Product by Botrytis sp. | |
KR20190017325A (en) | Method for preparing extract of fermented silkworm cocoon for improving antiwrinkle and a cosmetic composition containing the fermented extract of silkworm cocoon as an active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right |